HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of mebendazole in the treatment of Taenia saginata taeniasis in an endemic area in the Philippines.

Abstract
The successful treatment of Taenia saginata taeniasis with mebendazole is herein reported. 41 subjects ascertained to have taeniasis based on the history of passage of gravid segments and positivity for Taenia egg were treated with 300 mg mebendazole b.i.d. for 3 days without need for fasting. No side-effects were observed. The drug acts as a taeniacide. The worms were expelled either as degenerated boluses or fragmented segments on the 2nd to the 4th day (Mean: 2.4 days) after the initial dose. 33 (84.6%) of the 41 subjects expelled the worm. A follow-up of all the subjects 2--3 months after treatment revealed that all those who expelled the worm following treatment and 6 of those who did not were negative for both Taenia egg and gravid segment, or a cure rate of 95%.
AuthorsP V Arambulo 3rd, B D Cabrera, M G Cabrera
JournalActa tropica (Acta Trop) Vol. 35 Issue 3 Pg. 281-6 (Sep 1978) ISSN: 0001-706X [Print] Netherlands
PMID31782 (Publication Type: Journal Article)
Chemical References
  • Benzimidazoles
  • Mebendazole
Topics
  • Adolescent
  • Adult
  • Aged
  • Benzimidazoles (therapeutic use)
  • Child
  • Disease Reservoirs
  • Female
  • Humans
  • Male
  • Mebendazole (therapeutic use)
  • Middle Aged
  • Philippines
  • Taeniasis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: